Literature DB >> 7569129

MR angiography of congenital heart disease in adults.

G G Hartnell1, R A Meier.   

Abstract

Magnetic resonance (MR) angiographic techniques are useful in evaluation of adult patients with congenital heart disease (CHD). The available techniques include cine, breath-hold ungated, and segmented k-space time-of-flight MR angiography. Three-dimensional (3D) image reconstruction with maximum-intensity projection can be used with all of these techniques to demonstrate great vessel anomalies associated with CHD. Selective presaturation MR angiography can be used to detect intracardiac shunts. MR angiography allows clarification of difficult diagnostic points that are not fully demonstrated with other imaging techniques, such as cardiac catheterization and angiocardiography, echocardiography, nuclear medicine studies, and conventional spin-echo MR imaging. In many patients with CHD in adulthood, the use of appropriate MR angiographic techniques may allow definitive diagnosis and preclude the need for cardiac catheterization. The wide field of view, sensitivity to shunts, and rapid 3D imaging capability of MR angiography make it a valuable method of evaluating CHD in adults.

Entities:  

Mesh:

Year:  1995        PMID: 7569129     DOI: 10.1148/radiographics.15.4.7569129

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  2 in total

1.  Multicenter review: role of cardiovascular magnetic resonance in diagnostic evaluation, pre-procedural planning and follow-up for patients with congenital heart disease.

Authors:  Nicolò Schicchi; Aurelio Secinaro; Giuseppe Muscogiuri; Paolo Ciliberti; Benedetta Leonardi; Teresa Santangelo; Carmela Napolitano; Giacomo Agliata; Maria Chiara Basile; Francesca Guidi; Paolo Tomà; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2015-12-11       Impact factor: 3.469

Review 2.  MR imaging of congenital heart diseases in adolescents and adults.

Authors:  Y H Choe; I S Kang; S W Park; H J Lee
Journal:  Korean J Radiol       Date:  2001 Jul-Sep       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.